RMT (RMT) Stock Price & Analysis
RMT (RMT) fell 0.72% to USD 13.7 as of June 10, 2026 at 02:23 UTC, according to Nexqual real-time market data.
RMT last closed at USD 13.8; the session ranged USD 13.35–13.99 on volume of 164,316 shares. Market capitalization is $732.66M, with a 52-week range of USD 8.66–14.3 (NYQ). Source: Nexqual, June 10, 2026 at 02:23 UTC.
Key Statistics (as of June 10, 2026 at 02:23 UTC)
| Price | USD 13.7 |
|---|---|
| Change | ▼ 0.72% (down) |
| Previous Close | USD 13.8 |
| Open | USD 13.83 |
| Day Range | USD 13.35 – 13.99 |
| 52-Week Range | USD 8.66 – 14.3 |
| Volume | 164,316 shares |
| Market Cap | $732.66M |
| Exchange | NYQ |
Technical Analysis (RMT)
Nexqual's technical model rates RMT "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 02:23 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.63 (neutral) |
| vs SMA50 | Above (USD 13.14) |
| MACD | 0.21 (positive) |
Analyst Ratings (RMT)
Wall Street analysts rate RMT "None", per Nexqual as of June 10, 2026 at 02:23 UTC.
| Consensus Rating | None |
|---|
Earnings (RMT)
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Financials & Fundamentals (RMT)
| Total Revenue | $4.92M |
|---|---|
| Revenue Growth (YoY) | -19.40% |
| Gross Margin | +100.00% |
| Operating Margin | -55.63% |
| Profit Margin | +1782.03% |
| ROE | +14.66% |
| Debt / Equity | 3.17 |
| Current Ratio | 0.54 |
| Total Cash | $38,529 |
| Total Debt | $20.00M |
| Free Cash Flow | $822,394 |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Financial Health Score (RMT)
Nexqual rates RMT's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:23 UTC.
| Growth | Critical — Revenue -19% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Solid — $39K cash vs $20M debt |
| Cash Flow | Strong — FCF $822K, 17% margin |
| Efficiency | Mixed — ROE 15%, ROA -0.2% |
Ownership (RMT)
| Insider Ownership | +0.21% |
|---|---|
| Institutional Ownership | +38.02% |
| Shares Outstanding | 53.48M |
| Short % of Float | +0.08% |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Leadership (RMT)
RMT is led by Charles Morgan Royce (age 85), Portfolio Manager and Chairman, per Nexqual as of June 10, 2026 at 02:23 UTC.
| Portfolio Manager and Chairman | Charles Morgan Royce (age 85) |
|---|
Major Backers & Investors (RMT)
Notable institutional backers of RMT include Saba Capital Management, L.P., Morgan Stanley, LPL Financial LLC, according to Nexqual as of June 10, 2026 at 02:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Saba Capital Management, L.P. | 5.64% |
| Morgan Stanley | 5% |
| LPL Financial LLC | 2.06% |
| Modern Wealth Management, LLC | 1.95% |
| Allspring Global Investments Holdings, LLC | 1.93% |
| Alexander Randolph Advisory, Inc. | 1.86% |
| RiverNorth Capital Management, LLC | 1.71% |
| UBS Group AG | 1.65% |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RVT | Royce Value Trust, Inc. | USD 17.75 | ▲ 0.68% |
| ASG | Liberty All-Star Growth Fund, I | USD 5.25 | ▲ 0.96% |
| FUND | Sprott Focus Trust, Inc. - Clos | USD 10.09 | ▼ 0.59% |
| HQL | TeklaLife Sciences Investors | USD 16.78 | ▼ 0.83% |
| RFI | Cohen & Steers Total Return Rea | USD 11.34 | ▼ 0.44% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:23 UTC. This page is informational and not investment advice.